Teligent Retained Earnings (Accumulated Deficit) 2010-2021 | TLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent retained earnings (accumulated deficit) from 2010 to 2021. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Teligent Retained Earnings (Accumulated Deficit) 2010-2021 | TLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Teligent retained earnings (accumulated deficit) from 2010 to 2021. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$19.4B
Dr Reddy's Laboratories (RDY)	$11.9B
BridgeBio Pharma (BBIO)	$4.4B
Bausch Health Cos (BHC)	$2.9B
Amphastar Pharmaceuticals (AMPH)	$2.2B
Supernus Pharmaceuticals (SUPN)	$2B
Taysha Gene Therapies (TSHA)	$506M
Personalis (PSNL)	$245M
Assembly Biosciences (ASMB)	$96M
Sol-Gel Technologies (SLGL)	$15M
Evoke Pharma (EVOK)	$6M